Alpenglow Biosciences Expands Advisory Board with Two Esteemed Industry Leaders

Alpenglow Biosciences Expands Advisory Board with Two Esteemed Industry Leaders

Seattle, WA – April 3, 2025 – Alpenglow Biosciences, a leader in advanced digital pathology and 3D tissue imaging, has announced the appointment of Blandine Merino, M.S., and Mike Rice to its Advisory Board. They join Dr. Jesse Salk, M.D., Ph.D., bringing decades of combined experience across next-generation sequencing (NGS), digital pathology, AI-driven cancer detection, and life science tools.

This expansion reflects Alpenglow’s ongoing commitment to accelerating innovation and delivering impactful solutions in precision medicine.

Blandine Merino

Blandine Merino brings more than 20 years of leadership in product development, strategy, and operations, with key roles at Guardant Health, Freenome, and Agilent Technologies. She has led initiatives in NGS testing, AI-powered cancer diagnostics, and strategic partnerships with both academic institutions and biopharma. At Agilent, she was instrumental in defining a digital pathology strategy for companion diagnostics, integrating advanced imaging with AI.

Mike Rice

Mike Rice, former Chairman and CEO of BioLife Solutions, offers extensive experience in scaling life science tools businesses. During his 17-year tenure, he oversaw BioLife’s growth from under $1 million in revenue to nearly $150 million, driven by strategic acquisitions and expansion in biopreservation technologies.

“We are thrilled to welcome Blandine and Mike to our Advisory Board,” said Nicholas Reder, MD, MPH, CEO and founder of Alpenglow Biosciences. “Their deep industry insights and proven leadership will be invaluable as we accelerate our efforts to transform pathology and precision medicine.”

Alpenglow’s proprietary platform enables full-volume 3D imaging of intact tissues, empowering clinical diagnostics and research with unprecedented clarity. The addition of these advisors positions the company for its next phase of innovation and growth.

Welcome, Blandine and Mike!